Conjunctival impression cytology in non-proliferative and proliferative diabetic retinopathy

被引:5
|
作者
Citirik, Mehmet [1 ]
Berker, Nilufer [1 ]
Haksever, Hulya [2 ]
Elgin, Ufuk [1 ]
Ustun, Huseyin [2 ]
机构
[1] SB Ankara Ulucanlar Eye Educ & Res Hosp, TR-06230 Ankara, Turkey
[2] SB Ankara Training & Res Hosp, Dept Pathol, TR-06230 Ankara, Turkey
关键词
conjunctiva; diabetes; impression cytology; retinopathy; OCULAR SURFACE; TEAR SECRETION; EYE;
D O I
10.3980/j.issn.2222-3959.2014.02.23
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
AIM: To examine the integrity of the ocular surfaces of subjects with and without diabetes with no conjunctival and dry eye signs and symptoms and compare conjunctival impression cytology findings in diabetics with non-proliferative and proliferative diabetic retinopathy. METHODS: Conjunctival impression cytology was performed on 43 eyes of 43 subjects with non - proliferative diabetic retinopathy (NPDR), 42 eyes of 42 subjects with proliferative diabetic retinopathy (PDR), and 30 eyes of 30 control subjects. Impression cytology specimens of each group were graded and scored in the range 0-3 according to Nelson's method. RESULTS: There were 45 (52.9%) women and 40 (47.1%) men. The mean age of the patients was 59.6 +/- 9.3y (range, 43-76y) in NPDR group and 58.0 +/- 8.8y (range, 41 -85y) in PDR group. Cases with NPDR and PDR showed statistically significant higher impression cytology scores than control group (P<0.05). There was no difference between the NPDR and PDR patients for impression cytology grading scores. CONCLUSION: It is determined that impression cytology grades are altered in patients with NPDR and PDR. Consequently, we suggest that there might be an association between the impression cytology grading scores and the severity of diabetic retinopathy
引用
收藏
页码:321 / 325
页数:5
相关论文
共 50 条
  • [41] Effect of sulodexide in patients with non-proliferative diabetic retinopathy: diabetic retinopathy sulodexide study (DRESS)
    Ji Hun Song
    Hee Seung Chin
    Oh Woong Kwon
    Su Jin Lim
    Ha Kyoung Kim
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2015, 253 : 829 - 837
  • [42] Anaemia and the risk of progression from non-proliferative diabetic retinopathy to vision threatening diabetic retinopathy
    Li, Yafeng
    Yu, Yinxi
    VanderBeek, Brian L.
    EYE, 2020, 34 (05) : 934 - 941
  • [43] Characterisation of human non-proliferative diabetic retinopathy using the fractal analysis
    Stefan Tǎlu
    Dan Mihai Cǎlugǎru
    Carmen Alina Lupascu
    International Journal of Ophthalmology, 2015, (04) : 770 - 776
  • [44] Effect of propylene glycol mannate sulfate on non-proliferative diabetic retinopathy
    Wang, Mingming
    Song, Bangjian
    Xu, Haining
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2024, 16 (06): : 2509 - 2516
  • [45] PROGNOSIS OF NON-PROLIFERATIVE DIABETIC-RETINOPATHY DURING TREATMENT WITH GLICLAZIDE
    REGNAULT, AF
    PHILIPPINE JOURNAL OF INTERNAL MEDICINE, 1980, 18 (02): : 93 - 99
  • [46] Non-proliferative diabetic retinopathy - new findings in indocyanine green angiography
    Yassur, Y
    Weinberger, D
    Kremer, M
    Gaton, D
    Axer-Siegal, R
    Priel, ER
    RETINAL PIGMENT EPITHELIUM AND MACULAR DISEASES, 1998, 62 : 397 - 399
  • [47] DETECTION OF NON-PROLIFERATIVE DIABETIC RETINOPATHY IN FUNDUS IMAGES OF THE HUMAN RETINA
    Silvia, R. Catherine
    Vijayalakshmi, R.
    2013 INTERNATIONAL CONFERENCE ON INFORMATION COMMUNICATION AND EMBEDDED SYSTEMS (ICICES), 2013, : 986 - 991
  • [48] Anaemia and the risk of progression from non-proliferative diabetic retinopathy to vision threatening diabetic retinopathy
    Yafeng Li
    Yinxi Yu
    Brian L. VanderBeek
    Eye, 2020, 34 : 934 - 941
  • [49] NON-PROLIFERATIVE DIABETIC RETINOPATHY: IS IT COST-EFFECTIVE TO TREAT EARLY?
    Mistry, H.
    Auguste, P.
    Lois, N.
    Waugh, N.
    VALUE IN HEALTH, 2014, 17 (07) : A609 - A609
  • [50] Estimation of severity level of non-proliferative diabetic retinopathy for clinical aid
    Kaur, Jaskirat
    Mittal, Deepti
    BIOCYBERNETICS AND BIOMEDICAL ENGINEERING, 2018, 38 (03) : 708 - 732